As more healthcare businesses tap into the power of cloud computing, pharmaceutical and biotechnology research company Schrodinger is using communications provider BT’s (News - Alert) cloud platform in its effort to accelerate the process of drug development.

Schrodinger, which is now a “strategic member” of the BT for Life Sciences partner ecosystem, is helping provide research solutions to scientists on a global basis.  The company’s software tools will be integrated into BT for Life Sciences, as part of BT’s R&D Workbench environment, according to Dr. Ramy Farid, president of Schrodinger.

“Integrating Schrodinger’s scientific breakthroughs with BT’s cloud services takes us one step closer in our mission to empower researchers to improve human health and quality of life through advanced computational techniques,” Farid said in a statement. “We believe that providing our applications in BT’s cloud environment could transform the way chemists discover and design compounds and drugs.”

Company officials said BT for Life Sciences is the first cloud service designed to enable collaboration within the life sciences industry for increased productivity in discovery, research and development.

One of Schrodinger’s most critical applications, hosted Seurat, will soon be available on the BT Cloud Compute Platform. The application contains tools that help researchers in the discovery and optimization of drug research and provides a means for sharing real-time analysis across the organization. 

Using BT’s cloud services for Life Sciences, Schrodinger can now offer their applications quickly and easily with a click-to-launch approach that uses secure, compliant, and scalable cloud computing, storage and databanks, in order to process demanding scientific analysis, according to Bas Burger, president of Pharmaceutical & Chemical for BT Global Services (News - Alert).

“Drawing on BT’s years of experience and expertise in the pharmaceutical industry, our cloud-based service can help accelerate the process of R&D for companies like Schrodinger,” Burger said. “Our goal is to provide the best solutions to our global pharmaceutical customers that will enable them to meet their mission.”